PerkinElmer Introduces Next Generation Cell Image Analysis and Management Software Platform to Help Streamline Drug Discovery Decision Making

Signals Image Artist helps scientists process and analyze 3D cell imaging, phenotypic and cell painting data in hours vs. days or weeks October 4, 2021 WHAT: PerkinElmer, Inc ., a global leader committed to innovating for a healthier world, today announced the launch of Signals Image Artist™ software, a next generation image analysis and management... Read more

Phase II/III trial shows Ronapreve™ (casirivimab and imdevimab) significantly reduces viral load within seven days of treatment in patients hospitalised with COVID-19

Trial met primary endpoint, showing Ronapreve significantly reduced viral load in seronegative patients hospitalised with COVID-19 who did not require high-flow oxygen or mechanical ventilation at baseline Clinical data complement previous findings in hospitalised setting, including from United Kingdom (UK) University of Oxford-led RECOVERY trial Basel, 30 September 2021 – Roche (SIX: RO, ROG; OTCQX:... Read more

IBM Research and Arctoris accelerate closed loop drug discovery with AI and Cloud

Oxford and Zurich – 13 September 2021 – Life Science Newswire – Today, IBM Research and Arctoris announced they are investigating the application of AI and automation to accelerate closed loop molecule discovery. IBM Research has developed RXN for Chemistry, an online platform leveraging state-of-the-art Natural Language Processing (NLP) architectures to automate synthetic chemistry. Representing chemical reactions via SMILES (Simplified Molecular... Read more

SCIEX builds on cadence of innovation in biopharma with Biologics Explorer

New application software enables protein characterization analysis for the ZenoTOF 7600 system September 01, 2021 Framingham, MA — SCIEX, a global leader in life science analytical technologies and Danaher operating company, launches Biologics Explorer software, enabling customers to acquire insights from their high-resolution protein characterization data, and reach decisions quickly and confidently on the most important... Read more

Roche receives FDA approval for first companion diagnostic to identify dMMR solid tumour patients eligible for anti-PD-1 immunotherapy

Cancer is the second leading cause of death worldwide, with nearly 10 million deaths annually.1, 2 In the U.S., approximately 1.9 million new cancer cases are expected to be diagnosed in 2021.1 Based on cancer biomarkers, the first-of-its-kind VENTANA MMR RxDx Panel helps determine which solid tumour patients may benefit from GSK immunotherapy. Roche/GSK collaboration... Read more

[Ad hoc announcement pursuant to Art. 53 LR] Phase III study shows Roche's Polivy plus R-CHP is the first regimen in 20 years to significantly improve outcomes in previously untreated aggressive form of lymphoma compared to standard of care

Pivotal phase III POLARIX trial comparing Polivy in combination with chemotherapy regimen R-CHP versus the standard of care R-CHOP in treatment of first-line diffuse large B-cell lymphoma (DLBCL) met its primary endpoint of investigator-assessed progression-free survival Prolonging survival without disease advancement could be transformative for newly diagnosed DLBCL patients as currently 40% of patients relapse... Read more

Strategic partnership between Genedata and SCIEX deepens and accelerates characterization of next generation biotherapeutics

The collaboration will drive the development of new software solutions for in-depth characterization of novel biotherapeutics during the drug development process. July 29, 2021 Framingham, MA, USA and Basel, Switzerland — SCIEX, a global leader in life science analytical technologies, and Genedata, leading provider of biopharma enterprise software solutions, have entered into a strategic partnership to develop new software... Read more

PerkinElmer Expands KRAS Oncology Drug Discovery Assays with New Ready-to-Use AlphaLISA Kits

Mailing addressesCorrespondence should be mailed to:ComputershareP.O. Box 505000Louisville, KY 40233 Overnight correspondence should be sent to:Computershare462 South 4th Street, Suite 1600Louisville, KY 40202 Shareholder website www.computershare.com/investorShareholder online inquirieswww-us.computershare.com/investor/Contact Read more

Waters to Help Accelerate Biologics Production Through Research Collaboration With Singapore’s Bioprocessing Technology Institute

06/28/21 Project Explores LC-MS Data Analytics Methods to Rapidly Characterize Complex Biomolecules NEWS SUMMARY: Waters expands collaboration with Bioprocessing Technology Institute, A*STAR into new areas meant to accelerate bioprocessing and bioinformatics research. Projects include developing analytical workflows for nucleic acid therapeutic products and bioinformatics research to deliver robust and accurate identification for a variety of... Read more